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ABSTRACT  
Objectives: The giant Lausannevirus was recently identified as a parasite of amoeba that 
replicates rapidly in these professional phagocytes. This study aimed at assessing 
Lausannevirus seroprevalence among asymptomatic young men in Switzerland and hopefully 
identifying possible sources of contact with this giant virus.  
Methods: The presence of anti-Lausannevirus antibodies was assessed in sera from 517 
asymptomatic volunteers that filled a detailed questionnaire. The co-reactivity between 
Lausannevirus and amoeba-resisting bacteria was assessed. 
Results: Lausannevirus prevalence ranged from 1.74 to 2.51%. Sporadic condom use or 
multiple sexual partners, although frequent (respectively 53.97% and 60.35%), were not 
associated with anti-Lausannevirus antibodies. On the contrary, frequent outdoor sport 
practice as well as milk consumption were significantly associated with positive 
Lausannevirus serologies (p-value=0.0066 and p-value=0.028, respectively). Co-reactivity 
analyses revealed an association between Criblamydia sequanensis (an amoeba-resisting 
bacterium present in water environments) and Lausannevirus seropositivity (p-value=0.001). 
Conclusions: Lausannevirus seroprevalence is low in asymptomatic Swiss men. However, the 
association between virus seropositivity and frequent sport practice suggests that this member 
of the Megavirales may be transmitted by aerosols and/or exposure to specific outdoor 
environments. Milk intake was also associated with seropositivity. Whereas the co-reactivity 
observed for Criblamydia sequanensis and Lausannevirus reflects a common mode of 
acquisition or some unexpected cross-reactivity remains to be determined. 
 
 
 
 
INTRODUCTION 
Lausannevirus is a new member of the Marseilleviridae family, which is part of the 
Megavirales [1]. It has been discovered by amoebal co-culture in 2005 from a sample 
collected in the Seine river (Paris, France) [2]. Lausannevirus is rapidly growing in amoebal 
co-culture using Acanthamoeba as cell background, with a 3 log increase in 16 hours and 
complete amoebal lysis after about 24h [2]. 
The Marseilleviridae family contains two more members: Marseillevirus [3] and Senegalvirus 
[4]. The latter strain was recovered from the stools of an asymptomatic individual in Senegal, 
demonstrating that humans may be exposed to these large viruses. It is thus important to study 
the ecology and the possible medical importance of Lausannevirus and other Marseilleviridae 
in addition to understanding their biology.  
The genome of Lausannevirus is 346,754 bp long and contains 450 genes. It exhibits a strong 
synteny with the 2 distal thirds of the genome of Marseillevirus [1,2]. Interestingly, this 
icosahedral virus has a size of about 200 nm, allowing its observation by optical microscope 
[2]. This allowed the straightforward development of a micro-immunofluorescence assay 
using whole Lausannevirus viral particle as antigen.  
This serological assay was then applied to 517 asymptomatic young adults, in order to 
determine the seroprevalence and ideally identify some specific source of exposure to 
Lausannevirus. 
 
 
 
 
 
METHODS 
Patients and Statistical analyses: We took advantage of the availability of sera from previous 
seroprevalence studies on Chlamydia trachomatis and Chlamydia-like organisms [5,6]. All Swiss 
young men who presented at the medical entry examination at the Army recruitment Centre of 
Lausanne in winter 2006-2007 were enrolled in this study. A questionnaire was filled to collect 
demographic data, sexual and behavioural risk as well as animal exposure. Sera were analyzed by 
immunofluorescence (see below), using as antigen Lausannevirus particles grown in amoebae and 
purified by ultracentrifugation (see below). 
Statistical analyses were performed using R [7]. 
Growth of Lausannevirus: Lausannevirus was grown in Acanthamoeba castellanii ATCC 
30010 as described previously [2]. Briefly, we filtered at 5µm a one week infected A. 
castellanii flask grown in peptone yeast-extract glucose (PYG) at 32°C and we re-infected a 
new flask with the filtrate. Five days later, the virus was harvested and flask supernatant was 
centrifuged at 5000 g for 15 min. The supernatant was then collected and filtered at 5µm to 
remove residual amoebal cells. The filtrate was then centrifuged at 35’000 g for 1h and the 
virus pellet was resuspended in 1 ml of PBS. 
Immunofluorescence: Sera were investigated as described previously [8], by micro-
immunofluorescence (MIF), using formaldehyde-inactivated viral particles as antigen. Briefly, sera 
were screened for Lausannevirus antibodies at a dilution of 1:64 with FluolineH. Mice polyclonal anti-
Lausannevirus antibodies were used as positive control and PBS was used as negative control. IgG and 
IgM reactivity were tested for sera exhibiting a total Ig titre ≥1:64, as previously described [9]. IgG 
and IgM positivity cut-offs were ≥1:32. Blind lecture of each micro-immunofluorescence was 
performed by two independent observers.  A targeted lecture of 11 doubtful samples was performed by 
a third reader.  
 
 
RESULTS 
According to the first reader, among the 517 volunteers tested, aged from 18 to 26 years, 13 
exhibited antibody reactivity against Lausannevirus, corresponding to a Lausannevirus 
seroprevalence of 2.51%. Among the 13 seropositive patients identified by the first reader, 9 
were confirmed by at least one of the additional readers, reducing the seroprevalence rate to 
1.74%. Considering all 13 positive patients, demographic, social and behavioural 
characteristics as well as animal contact are reported in Table 1. Among the seropositive 
volunteers, 84.6% were Swiss, 61.5% lived in cities with more than 10’000 inhabitants and 
61.5% were students. A total of 84.5% of participants reported to be sexually-active and 
60.35% of them admitted to have had more than two previous partners. However, no 
correlation was observed between Lausannevirus seropositivity and sexual behaviour (Table 
1).  Among the 517 volunteers 58.79% had contact with animals but, again, no association has 
been observed (Table 1). Other behavioural risks have also been analysed, showing no 
correlation between virus infection and smoking, alcohol intake or drug consumption (Table 
1). On the contrary, frequent sport practice and milk consumption were associated with 
Lausannevirus seropositivity (p-value=0.0066 and p-value=0.028 respectively). Analysis on 
the 9 patients showing anti-Lausannevirus antibodies reported that the correlation between 
Lausannevirus seropositivity and milk consumption was maintained (p-value=0.02). On the 
contrary the correlation with a frequent sport activity was no longer statistically significant (p-
value=0.06). 
 
 
 
 
 
DISCUSSION 
This first Lausannevirus sero-epidemiological study performed among 517 young 
asymptomatic Swiss adults demonstrated that humans might be exposed to Lausannevirus 
and/or other related cross-reactive viruses (Table 1). The relatively low seroprevalence 
observed (1.74-2.51%) may be explained by the characteristics of the target population which 
is composed exclusively of asymptomatic young Swiss men. Since this is the first study 
investigating Lausannevirus seroprevalence, no data from others countries or from different 
target populations are available to draw any comparison. 
Further investigations revealed no correlation between seropositivity and sexual behaviour or 
animal contact, excluding sexual and zoonotic exposure to Lausannevirus (Table 1). Frequent 
sport practice has been shown to be strongly associated with seropositivity (p-value=0.0066). 
Sportspeople have an active social life, allowing meeting and socializing with many persons 
sharing the same exercise environments, as example, gyms or swimming pool. Also, most of 
the sports are practiced outdoor (as example mountain or forests), which may represent 
another exposure route. Taken together, these observations suggest that human get in contact 
with Lausannevirus by exposure to water or soil during sportive activities. Milk consumption 
has also been shown to be associated with Lausannevirus seropositivity (p-value=0.028). It is 
possible that cows may shed Lausannevirus particles in the milk, however this remains to be 
studied. Since previous studies focused on C. trachomatis and Chlamydia-like prevalence on 
the same target population [5,9], we investigated for a potential co-reactivity between these 
bacterial species and Lausannevirus. Unexpectedly, we observed a strong association between 
Lausannevirus seropositivity and antibodies directed against C. sequanensis (p-value=0.001) 
(Table 2). Conversely, we observed no co-reactivity between Lausannevirus and W. 
chondrophila, which has been identified in bovine abortion and which is considered to be a 
possible zoonotic agent [6,8].  
Co-reactivity with C. sequanensis may be due to a common mode of exposure because C. 
sequanensis is a Chlamydia-related bacterium generally associated with water and free-living 
amoebae and Lausannevirus has been isolated from water by amoebal co-culture. Thus, 
amoebae might act as a reservoir of Lausannevirus and human might get infected following 
exposure to contaminated water, similarly to what is known for Legionella [10]. Whether 
amoebae act as a Trojan horse by increasing the viral infectivity remains to be determined. 
Nevertheless, the resistance to amoebal microbicidal effectors may be associated with 
resistance to microbicidal effectors of human macrophages [11]. Conversely, the absence of 
co-reactivity with C. trachomatis (p-value>0.05), the most common sexually transmitted 
bacteria, suggests that Lausannevirus is not sexually transmitted and is congruent with our 
observed absence of association between seroprevalence and risky sexual behavior. However, 
due to the limited number of patients exhibiting anti-C. trachomatis antibodies, we were not 
able to definitely rule out a sexual transmission.  
Co-reactivity with C. sequanensis may also arise as a result of cross-reactivity with a shared 
epitope. However, this latter hypothesis is unlikely, since Lausannevirus is distantly related to 
C. sequanensis. BLASTP analysis for small highly conserved peptides between these two 
microorganisms revealed that only one peptide of 10 amino acids in the deoxyuridine 5'-
triphosphate nucleotidohydrolase is identical (100%). Thus, the recognition of a linear epitope 
is unlikely. However we are not able to exclude a possible recognition of conformational 
epitopes. Although the described co-reactivity between Lausannevirus and an amoeba-
resisting bacterium suggests a seroconversion following infection by Lausannevirus-
containing amoebae, we cannot exclude the possibility that Lausannevirus is able to directly 
infect humans, without using amoebae as a Trojan horse. In fact, recent studies demonstrated 
the presence of viruses of Marseilleviridae and Mimiviridae families in human samples 
[1,12]. 
For the future, we suggest to expand the seroprevalence studies to other countries, as for 
example France and Senegal, from where Lausannevirus, Marseillevirus and Senegalvirus 
have been isolated. Furthermore, the sampling population should be increased and include 
persons with various infectious diseases of unknown etiology, people from different ages, as 
well as women, since seroprevalence may be gender dependent. Moreover, it will be 
interesting to evaluate whether Lausannevirus is circulating in the blood of asymptomatic 
subjects by using a specific PCR, which exhibits a high sensitivity.   
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Table 1 . Lausannevirus prevalence according to demographic, social and behavioural factors among 
517 young Swiss male 
Characteristics 
Lausannevirus positive n=13 (2.51%) Lausannevirus negative n=504 (97.49%) p-value* 
    Nationality at birth    Switzerland 11 (84.62%) 424 (84.13%) 1 Other 2 (15.38%) 80 (15.87%)  
Place of residence**    >10'000 inhabitants 8 (61.54%) 209 (41.47%) 0.26 <10'000 inhabitants 5 (38.46%) 279 (55.36%)  
Main occupation**    Studies 8 (61.54%) 199 (39.48%) 0.26 Work 5 (38.46%) 269(53.37%)  
Contact with animals    Animal contact 5 (38.46%) 260 (51.6%) 0.41 No animal contact 8 (61.54%) 244 (48.41%)  
Smoke/drugs    Cigarettes 4 (30.77%) 242 (48.02%) 0.26 Cannabis 3 (23.08%) 137 (27.18%) 1.00 Drugs 0 (0%) 23 (4.56%) 1.00 Alcohol ≥ 2x/week 10 (76.92%) 341 (67.66%) 0.37 
Any reported disease    Asthma 0 (0%) 35 (6.94%) 1.00 
Sport practice**    
≥ 3x/ week 5 (38.46%) 83 (16.46%) 0.0066 
≤ 3x/week 1 (7.69%) 235 (46.62%)  
Milk consumption**    Milk consumption 11 (84.62%) 494 (98.01%) 0.028 No milk consumption 2 (15.38%) 9 (1.79%)  
Sexual orientation**    Heterosexual 8 (61.54%) 382 (75.79%) 0.17 Homo/bisexual 1 (7.69%) 8 (1.59%)  
Condom use**    Always 5 (38.46%) 158 (31.34%) 0.55 Sometimes 7 (53.84%) 313 (62.1%)       *Fisher's exact chi2    **Some patients declined to answer to this question and were excluded from statistical analysis                                                                         
Table 2. Co-reactivity between Lausannevirus and Chlamydia as well as Chlamydia-related organisms 
Bacteria Bacteria positive Lausannevirus positive n=13 (2.51%) Lausannevirus negative n=504 (97.49%) p-value*      Waddlia chondrophila 167 (32.3%) 5 (38.46%) 162 (32.14%) 0.67      Criblamydia sequanensis 252 (48.74%) 9 (69.23%) 243 (48.21%) 0.001 
     Parachlamydia 
acanthamoebae 17 (3.29%) 1 (7.69%) 16 (3.17%) 0.37 
     Protochlamydia naegleriophila 4 (0.77%) 1 (7.69%) 3 (0.60%) 0.1      Chlamydia trachomatis 6 (1.16%) 1 (7.69%) 5 (1.00%) 0.14 *Fisher's exact chi2           
 
 
 
 
 
 
 
 
 
  
